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Summary
Hypertrophic cardiomyopathy (HCM) has been
considered rare among the Black population of
southern Africa. We report 7 patients with the dis-
ease who presented during a 14-month period. Cur-
rent concepts in the approach to the diagnosis and
treatment of HCM are discussed. It is possible that
with gr~ater awareness of the occurrence of the
condition in Blacks the diagnosis of HCM will be
made in more members of this population group.
S Air Med J 1983; 63: 266-269.
Hypertrophic cardiomyopathy (HCM) is an important cardiac
lesion to diagnose. Although some patients are asymptomatic,
others complain of angina pectoris, syncope or shortness of
breath, and sudden death may occur. I The disease is often famil-
ial, inherited as a mendelian dominant gene with variable
penetrance.2
HCM is not uncommon among White South Africans' but
only 4 Black HCM patients have been reported,4.5 and the dis-
ease has been considered to be rare in this racial group. We report
7 Black patients with HCM seen in the Division of Cardiology,
Baragwanath Hospital, over a 14-month period, in order to draw
attention to the condition in South African Blacks. The diagnosis
and current concepts of the pathophysiology and management of
HCM are discussed.
Patients and methods
The clinical data are summarized in Table 1. All patients claimed
to be of pure Black descent. They belonged to differen~ Bantu
tribes: there were 3 Tswanas, 2 Xhosas and 1 each of Zulu and
Venda origin. Five of the 7 were males and all were young (age
range 19-38 years). Anginal-type chest pain was the presenting
symptom in 5 patients. One patient claimed to be asymptomatic
except for having had two episodes of acute breathlessness, for
which he was admitted to hospital with pulmonary oedema. The
7th patient was asymptomatic and had been referred for evalua-
tion ofa harsh systolic murmur detected during routine physical
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examination for insurance purposes. The duration of symptoms
varied, but only 1 (patient 5) had a.history exceeding 2 years.
Physical examination revealed left ventricular hypertrophy
(1. VH) in all patients, with a prominent presystolic irripulse at
the apex in 6. A 'jerky', rapidly rising pulse was readily <Ipparent
in 4. The splitting of the second heart sound was abnormally
narrow or partially reversed' in all 7 patients. All had a delayed
onset systolic ejection murmur; this increased in intensity on
standing and became softer on squatting in 3. The ECG showed
se\'ere 1.VH with T -wave inversion over the left ventricle in all
patients, in 4 of whom deep septal Qwaves were also present. In
only one instance (patient 5) was the heart enlarged as seen on
radiography, but all 7 had a shelf-like outline to the left heart
border which gave the left ventricle a 'bulky' appearance compat-
ible with 1.VH (Fig. I). Signs of pulmonary venous hypertension
were present in 4 patients.
Fig. 1. Postero-anterior chest radiograph of patient 7. The
cardiothoracic ratio is 0,50 but there is a prominent shelf-like
appearance to the left heart border which gives the left ventricle a
'bulky' appearance, and is compatible with LVH.
Echocardiography was diagnostic of HCM in all patients
(Table II). In 5 both M-mode and high quality real-time two-
dimensional echocardiograms were recorded, whereas in the
remaining 2 (patients 2 and 3) the M-mode technique only was
available. Echocardiography showed severe 1.VH (Fig. 2) in all
patients; the hypertrophy was asymmetrical, mainly involving
the septum, in 5. Systolic anterior motion (Fig. 3) of the anterior
mitral leaflet was present in these 5 patients, in 3 of whom
midsystolic closure of the aortic valve was also seen.
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TABLE I. CLINICAL, ELECTROCARDIOGRAPHIC AND RADIOGRAPHIC FINDINGS
Duration
Age Presenting of
Patient (yrs) Sex Race symptoms symptoms Disability' ECG Chest radiograph
28 M Tswana Chest pain, 2 yrs 2b Severe LVH, deep CTR 0,45, 'bulky' LV,
palpitations, septal a waves pulmonary venous
shortness of breath hypertension
2 19 M Zulu Chest pain 1 yr 2a Severe LVH, CTR 0,50, 'bulky' LV
prominent a waves in
leads I and V3-V6
3 19 M Xhosa Chest pain, 6 moo 2a Severe LVH, septal CTR 0,48, 'bulky' LV,
palpitations a waves in leads pulmonary venous
I and aVL hypertension




5 30: F Tswana Chest pain 10 yrs 2a Severe LVH CTR 0,63, 'bulky' LV,
\ pulmonary venous
hypertension
6 35 F Tswana Chest pain, 2 yrs 2b Severe LVH CTR 0,52 'bulky' LV,
palpitations, LA+, pulmonary venous
shortness of hypertension
breath
7 38. M Venda Asymptomatic Severe LVH, deep CTR 0,50, 'bulky' LV
j septal a waves
'''tow York Heart ASSOcIation graCIng
eR=- carOlO horaelc ratIO L = left ventrtcle. L H = left ventricular hypertrophy. LA- = left atrial enlargement.











150 0 Severe LVH
4,6,11
3 Severe LVH with small cavity, ASH,




Patient Echocardiography y,z,a gradient Angiography
Severe LVH with small cavity, ASH, 180 80 Severe LVH with septal
SAM of anterior mitral leaflet, 10,14,22 hypertrophy, trivial MI
midsystolic aortic leaflet closure
2 Severe LVH
5 Severe LVH with ASH, SAM of
anterior mitral leaflet, midsystolic
aortic leaflet closure
6 . Severe LVH with small cavity, ASH,
SAM of anterior mitral leaflet
7 Severe LVH with small cavity, ASH,
SAM of anterior mitral leaflet,
midsystolic aortic valve closure
125 10 Severe LVH, small 94
0,8,12 (35 on cavity and septal bulge
isoprenaline)
200 100 Severe LVH, small cavity 84
5,12,24 and septal bulge
ASH = asymmetric septal hypenrophy: SAM ::::; systolic anterior motion; MI = mitral incompetence: EF :;::: ejection fraction.
Cardiac catheterization (Table 1I) was performed in all except
patient 5. The left ventricular end-diastolic pressure was
increased in 3, and in a116 a prominent 'a' wave was recorded in
this chamber. An intraventricular pressure gradient was present
in 5 patients, but in the 6th there was no pressure difference at
rest, after an ectopic beat or during isoprenaline infusion. In all 6
left ventricular angiography confirmed marked LVH and
showed vigorous myocardial contraction with a markedly
increased ejection fraction and a small left ventricular cavity.
There was almost complete cavity obliteration of the ventricle in
4 of the 6 patients.
The patients were treated with a B-adrenergic blocking drug,
with the addition ofthe calcium antagonist verapamil in patients
I and 7. Symptoms improved in all, but patient I continues to
complain of chest pain.
!2cm
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Fig. 2. Real-time two-dimensional echocardiogram (subxiphoid four-chamber view) of patient 7 (end-diastolic frame). There is
marked LVH, especially of the interventricular septum. The left ventricular cavity is small (RV = right ventricle, LV = left ventricle, LA =
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Fig. 3. M-mode echocardiogram (patient 1), showing considerable hypertrophy of the left ventricular posterior wall (LVPW) and
especially of the interventricular septum (IVS). The anterior leaflet of the mitral valve (MV) shows abnormal systolic anterior motion
(arrowed). This coincides with a systolic notch in the carotid pulse tracing recorded simultaneously with the ECG.
Discussion
Pathophysiology of HCM
In HCM there is inappropriate and sometimes considerable
hypertrophy of the ventricular myocardium, predominantly
affecting the left ventricle. The excessive LVH has two principal
consequences: (I) ventricular relaxation and compliance are
abnormal, diastolic ventricular stiffness is increased, ventricular
filling is impaired and the end-diastolic pressure may be ele-
vated; and (ii) myocardial contraction is more forceful and the
distorted left ventricular cavity may produce an intraventricular
pressure difference during systole, but this is not an invariable
feature of the condition.6 The symptoms of HCM include angina
pecwn"s (due to increased myocardial oxygen demand and a
diminished diastolic coronary perfusion gradient), dyspnoea (the
clinical manifestation of the raised left ventricular end-diastolic
and left atrial pressures) and syncope (probably mainly due to
arrhythmias, but aggravated by the small left ventricular cavity
size which limits the stroke output). Sudden deach may super-
vene, especially during exercise or with emotion.
The pathogenesis of the inappropriate L VH is unknown.
There may be an inherited malformation of muscle in different
parts of the myocardium with fibre malalignment, resulting in
abnormal ventricular stresses and excessive hypertrophy.7 The
distribution of the abnormal regions would determine the pre-
cise geometry of the left ventricular cavity in a particular
patient,8 and where there is marked septal hypertrophy the
so-called 'obstructive' form of the disease usually results. In
most patients this 'obstruction' (as seen on angiography or echo-
cardiography) is subvalvar, but in a few instances it is midventri-
cular9 (hour-glass type). Hypertrophy confined to the apical
myocardium, giving a typical 'spade-like' appearance on angio-
graphy, has been emphasized by Japanese workers. lo It has been
argued,Il.12 however, that the pressure difference within the left
ventricular cavity does not reflect a true obstruction to left
ventricular emptying, but that rapid ejection during early systole
and cavity obliteration can account for many of the haemody-
namic, echocardiographic and angiographic features hitherto
attributed to 'obstruction'. 1I
Diagnostic features of HCM
The diagnosis ofHCM should be suspected in any patient who
has inappropriate, unexplained L VH. The arterial pulse often
has a rapid upstroke, in contrast to the slow-rising pulse ofaortic
stenosis, since in HeM early systolic ventricular emptying is
normal or increased. A second pulse wave, producing a bisferiens
character, may be felt in late systole. On auscultation a delayed
onset systolic murmur is almost always present, and this murmur
changes characteristically with various haemodynamic altera-
tions. 3 Splining of the second heart sound is abnormal and the
panern of the splining, whether narrow, reversed or partially
reversed, changes spontaneously within seconds and without
apparent cause.3 The ECG is seldom normal and commonly
suggests severe LVH. Deep septal Q waves may be present,
especially in patients with excessive septal hypertrophy. Electro-
cardiographic evidence of unexplained L VH should always raise
the possibility of HCM. The chest radiograph not infrequently
shows only slight or even no cardiac enlargement as assessed by
the cardiothoracic ratio. However, in our experience a shelf-like
appearance to the left heart border is characteristic of HCM, and
the diagnostic importance of this sign (Fig. 1) was confirmed in
the present series.
The echocardiogram is diagnostic in HCM and has probably
obviated the need for cardiac catheterization in most patients.
The echocardiogram, and especially the real-time two-dimen-
sional echocardiogram, shows the distribution and degree of
LVH, the forceful contraction of the left ventricle with cavity
obliteration, and the systolic anterior motion of the mitral valve
which is present in some patients and is anributed to asymmetri-
cal tension on the mitral apparatus by the distorted left ventricu-
lar geometry. Midsystolic flunering and closure of the aortic
leaflets are usually associated with a significant intraventricular
pressure gradient.
Management of HCM
The medical management of patients with HCM is aimed at
decreasing left ventricular contractility and increasing ventricu-
lar compliance and cavity size: Beta-receptor blockade13- 15 im-
proves the haemodynamic state and is effective in the treatment
of symptoms. The calcium antagonist verapamil 16 also improves
symptol1ls in many patients, and may dec(ease L VH after long-
term use. Using large doses of propranolol in conjunction with
anti-arrhythmic drugs and pacemakers, Canedo and Frank l ;
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were able to reduce the overall mortality rate of patients with
HCM to 0,5% per year. Since even asymptomatic patients are at
risk of sudden death, all patients with HCM should be given a
B-blocker or cakium antagonist at adequate dosage and should
und~J;go regular Holter monitoring in order to detect and treat
potentially life-threatening arrhythmias. Echocardiography is a
useful screening test for HCM, and should be used to detect
HCM in family members of patients with the disease.
In patients with large intracavitary gradients surgical inter-
vention (extensive left ventricular myectomy) may be indicated.
Although good results have been reported,11 it is not clear
whether this alters the long-term prognosis of the disease.
HCM in southern Africa
HCM is not uncommon in South African Whites,l but for
many years was not recognized in the Black population. The
disease may be less common in South African Blacks since there
- is a strong genetic factor. HLA typing has shown distinct trends
in the HLA panerns of patients with HCM, but the panerns vary
in different ethnic groups.18.19 HCM certainly occurs in North
American Blacks, and it is possible that many Black patients in
southern Africa have not been diagnosed because of having
nonspecific, relatively minor symptoms or signs. Screening of a
large number of subjects in this population by means of electro-
cardiography, radiography and echocardiography may enable
more cases to be diagnosed. The problem of diagnosis is com-
pounded by the fact that very large numbers of seriously ill Black
patients are examined and treated in southern Africa. In this
context patients with minor or atypical complaints (such as many
patients with HCM have) either do not consult a medical practi-
tioner or may not be referred to a specialist centre. Moreover,
-congestive cardiomyopathy is very co=on in this population,
and it is possible that some patients with unexplained cardiac
symptoms or cardiac enlargement are loosely diagnosed as hav-
ing 'cardiomyopathy' without further investigation or referral.
The fact that during the last 14 months we have seen 7 patients
with severe HCM identical to that seen elsewhere in the world
and to that occurring in White South Africans suggests that the
disease is not as rare in this group as has been thought. A greater
awareness of the condition may reveal more cases of HCM in the
South African Black population.
This study was supported in part by the Stella and Paul Loewen-
stein Cardiac Fund of the University of the Witwatersrand.
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Summary
Domperidone (Motilium) speeds the emptying rate
of the smallest particle size of a digestible solid
(radioactive cubed liver) but has no effect o'n the
emptying rate of 400 ml of 5% dextrose in the normal
canine stomach. Conversely, metoclopramide
(Maxolon) speeds the emptying of the liquid, but
slows the emptying rate of the digestible solid.
The effect of domperidone on canine gastric elec-
trical activity is to increase the frequency and
strength of action potentials in the stomach after
fasting and to slow the rate of discharge ofthe pace-
setter potential, an effect similar to that seen after
feeding.
S Afr Med J 1983: 63: 270-273.
Much information has been gained over the past years concern-
ing the effects and mode ofaction of metoclopramide (Maxolon)
on gastroduodenal motility. This drug, probably a dopamine
receptor blocker, has been shown to reverse the slowing ofgastric
emptying produced by dopamine and to speed the gastric empty-
ing of liquids, barium and solid meals. 1.2 The action of metoclo-
pramide appears to begin within 5 minutes and to last for at least
13 minutes. Terminal antral contractions and intragastric pres-
sure increase and there is better co-ordination between antral
and duodenal contractions. These effects have also been demon-
strated in patients after vagotomy. Howard and SharpJ were able
to produce more rapid emptying of the stomach of women in
labour with metoclopramide than with placebo. Others have
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found no effect in subjects with normal rates ofgastric emptying
but were able to speed the emptying rate in patients with delayed
gastric emptying.4 Metoclopramide has found a valuable place in
the treatment of patients with impaired motility of the upper
gastro-intestinal tract and has also been of use in upper gastro-
intestinal radiology and the placement of naso-intestinal tubes. 5
Similarly, domperidone (Motilium) antagonizes apomor-
phine-retarded gastric emptying6 and has the same effect on
dopamine-retarded gastric emptying.7 These authors showed
that it speeds the initial gastric emptying of a solid meal but has
no effect on a semi-solid meal. Domperidone produces dilation
of the pylorus.s
The aim of this study was to compare the effect of domperi-
done and metoclopramide on the gastric emptying ofa liquid (5%
dextrose) and a digestible solid (radioactive cubed liver) in dogs.
In addition we studied the effect of domperidone on the electri-
cal activity of the antrum and duodenum in dogs.
Material and methods
Gastric emptying studies
Ten mongrel dogs each weighing approximately 15 kg were
subjected to laparotomy under general anaesthesia, after which a
Thomas cannula was implanted into the duodenum approxi-
mately 10 cm distal to the pylorus. The cannulas were brought
through the anterior abdominal wall in the right flank and were
kept tightly closed with brass plugs when not being used for
gastric emptying studies. The animals were able to eat a normal
diet while the cannulas were in place and gained weight. When
the dogs had recovered from the operations, gastric emptying
studies using either 5% dextrose or radioactive cubed liver were
carried out.
Prior to a gastric emptying test each dog was starved of food
but not water for 24 hours. The animals were then placed in
loose-fining canvas slings, where the cannula was unstopped
and washed out with water. A Foley catheter was then directed -
via the cannula into the distal duodenum, where the bulb of the
catheter was inflated with 8 - 12 ml water containing mercuro-
chrome as a marker to indicate whether the balloon had burst.
The inflated balloon allowed for the total diversion of duodenal
